nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Immune system disorder—Linagliptin—type 2 diabetes mellitus	0.0104	0.0104	CcSEcCtD
Bromhexine—Abdominal pain upper—Glipizide—type 2 diabetes mellitus	0.0102	0.0102	CcSEcCtD
Bromhexine—Immune system disorder—Acarbose—type 2 diabetes mellitus	0.0101	0.0101	CcSEcCtD
Bromhexine—Abdominal pain upper—Pioglitazone—type 2 diabetes mellitus	0.00979	0.00979	CcSEcCtD
Bromhexine—Immune system disorder—Nateglinide—type 2 diabetes mellitus	0.00976	0.00976	CcSEcCtD
Bromhexine—Abdominal pain upper—Sitagliptin—type 2 diabetes mellitus	0.0095	0.0095	CcSEcCtD
Bromhexine—Angioedema—Linagliptin—type 2 diabetes mellitus	0.00918	0.00918	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.00875	0.00875	CcSEcCtD
Bromhexine—Abdominal pain upper—Bromocriptine—type 2 diabetes mellitus	0.0086	0.0086	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.0085	0.0085	CcSEcCtD
Bromhexine—Immune system disorder—Repaglinide—type 2 diabetes mellitus	0.00845	0.00845	CcSEcCtD
Bromhexine—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.0082	0.0082	CcSEcCtD
Bromhexine—Immune system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00799	0.00799	CcSEcCtD
Bromhexine—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00797	0.00797	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.00786	0.00786	CcSEcCtD
Bromhexine—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00724	0.00724	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.00716	0.00716	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.00716	0.00716	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.00708	0.00708	CcSEcCtD
Bromhexine—Angioedema—Rosiglitazone—type 2 diabetes mellitus	0.00703	0.00703	CcSEcCtD
Bromhexine—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00693	0.00693	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00688	0.00688	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.00687	0.00687	CcSEcCtD
Bromhexine—Immune system disorder—Pioglitazone—type 2 diabetes mellitus	0.0067	0.0067	CcSEcCtD
Bromhexine—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00665	0.00665	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.00663	0.00663	CcSEcCtD
Bromhexine—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00658	0.00658	CcSEcCtD
Bromhexine—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00658	0.00658	CcSEcCtD
Bromhexine—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00652	0.00652	CcSEcCtD
Bromhexine—Immune system disorder—Sitagliptin—type 2 diabetes mellitus	0.0065	0.0065	CcSEcCtD
Bromhexine—Abdominal pain upper—Valsartan—type 2 diabetes mellitus	0.00649	0.00649	CcSEcCtD
Bromhexine—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00646	0.00646	CcSEcCtD
Bromhexine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00645	0.00645	CcSEcCtD
Bromhexine—Abdominal pain upper—Orlistat—type 2 diabetes mellitus	0.00641	0.00641	CcSEcCtD
Bromhexine—Rash—Miglitol—type 2 diabetes mellitus	0.00639	0.00639	CcSEcCtD
Bromhexine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00638	0.00638	CcSEcCtD
Bromhexine—Urticaria—Acarbose—type 2 diabetes mellitus	0.00633	0.00633	CcSEcCtD
Bromhexine—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00628	0.00628	CcSEcCtD
Bromhexine—Urticaria—Nateglinide—type 2 diabetes mellitus	0.0061	0.0061	CcSEcCtD
Bromhexine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00604	0.00604	CcSEcCtD
Bromhexine—Nausea—Miglitol—type 2 diabetes mellitus	0.00602	0.00602	CcSEcCtD
Bromhexine—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00597	0.00597	CcSEcCtD
Bromhexine—Abdominal pain upper—Metformin—type 2 diabetes mellitus	0.00591	0.00591	CcSEcCtD
Bromhexine—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.0059	0.0059	CcSEcCtD
Bromhexine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00587	0.00587	CcSEcCtD
Bromhexine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00586	0.00586	CcSEcCtD
Bromhexine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00586	0.00586	CcSEcCtD
Bromhexine—Angioedema—Glimepiride—type 2 diabetes mellitus	0.00574	0.00574	CcSEcCtD
Bromhexine—Rash—Tolbutamide—type 2 diabetes mellitus	0.00574	0.00574	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.00574	0.00574	CcSEcCtD
Bromhexine—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.00573	0.00573	CcSEcCtD
Bromhexine—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00567	0.00567	CcSEcCtD
Bromhexine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00566	0.00566	CcSEcCtD
Bromhexine—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00561	0.00561	CcSEcCtD
Bromhexine—Abdominal pain upper—Irbesartan—type 2 diabetes mellitus	0.00558	0.00558	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00546	0.00546	CcSEcCtD
Bromhexine—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00545	0.00545	CcSEcCtD
Bromhexine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00543	0.00543	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00542	0.00542	CcSEcCtD
Bromhexine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00541	0.00541	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.0053	0.0053	CcSEcCtD
Bromhexine—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00528	0.00528	CcSEcCtD
Bromhexine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00527	0.00527	CcSEcCtD
Bromhexine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00527	0.00527	CcSEcCtD
Bromhexine—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00525	0.00525	CcSEcCtD
Bromhexine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00523	0.00523	CcSEcCtD
Bromhexine—Rash—Tolazamide—type 2 diabetes mellitus	0.00523	0.00523	CcSEcCtD
Bromhexine—Rash—Linagliptin—type 2 diabetes mellitus	0.00517	0.00517	CcSEcCtD
Bromhexine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00517	0.00517	CcSEcCtD
Bromhexine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00513	0.00513	CcSEcCtD
Bromhexine—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.00512	0.00512	CcSEcCtD
Bromhexine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00511	0.00511	CcSEcCtD
Bromhexine—Vomiting—Acarbose—type 2 diabetes mellitus	0.00506	0.00506	CcSEcCtD
Bromhexine—Rash—Acarbose—type 2 diabetes mellitus	0.00502	0.00502	CcSEcCtD
Bromhexine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00502	0.00502	CcSEcCtD
Bromhexine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00499	0.00499	CcSEcCtD
Bromhexine—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00497	0.00497	CcSEcCtD
Bromhexine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00492	0.00492	CcSEcCtD
Bromhexine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00492	0.00492	CcSEcCtD
Bromhexine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.0049	0.0049	CcSEcCtD
Bromhexine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00488	0.00488	CcSEcCtD
Bromhexine—Rash—Nateglinide—type 2 diabetes mellitus	0.00484	0.00484	CcSEcCtD
Bromhexine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00484	0.00484	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.0048	0.0048	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00475	0.00475	CcSEcCtD
Bromhexine—Angioedema—Glyburide—type 2 diabetes mellitus	0.00474	0.00474	CcSEcCtD
Bromhexine—Nausea—Acarbose—type 2 diabetes mellitus	0.00473	0.00473	CcSEcCtD
Bromhexine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.0047	0.0047	CcSEcCtD
Bromhexine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00456	0.00456	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00455	0.00455	CcSEcCtD
Bromhexine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00455	0.00455	CcSEcCtD
Bromhexine—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.0045	0.0045	CcSEcCtD
Bromhexine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.0045	0.0045	CcSEcCtD
Bromhexine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00444	0.00444	CcSEcCtD
Bromhexine—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.00444	0.00444	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00443	0.00443	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00442	0.00442	CcSEcCtD
Bromhexine—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.00439	0.00439	CcSEcCtD
Bromhexine—Urticaria—Glipizide—type 2 diabetes mellitus	0.00437	0.00437	CcSEcCtD
Bromhexine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.0043	0.0043	CcSEcCtD
Bromhexine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.00425	0.00425	CcSEcCtD
Bromhexine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00423	0.00423	CcSEcCtD
Bromhexine—Rash—Repaglinide—type 2 diabetes mellitus	0.00419	0.00419	CcSEcCtD
Bromhexine—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00419	0.00419	CcSEcCtD
Bromhexine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00419	0.00419	CcSEcCtD
Bromhexine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00418	0.00418	CcSEcCtD
Bromhexine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00408	0.00408	CcSEcCtD
Bromhexine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00406	0.00406	CcSEcCtD
Bromhexine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00405	0.00405	CcSEcCtD
Bromhexine—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00404	0.00404	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.004	0.004	CcSEcCtD
Bromhexine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00396	0.00396	CcSEcCtD
Bromhexine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00396	0.00396	CcSEcCtD
Bromhexine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00395	0.00395	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00394	0.00394	CcSEcCtD
Bromhexine—Angioedema—Valsartan—type 2 diabetes mellitus	0.00391	0.00391	CcSEcCtD
Bromhexine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00389	0.00389	CcSEcCtD
Bromhexine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00388	0.00388	CcSEcCtD
Bromhexine—Angioedema—Orlistat—type 2 diabetes mellitus	0.00386	0.00386	CcSEcCtD
Bromhexine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00381	0.00381	CcSEcCtD
Bromhexine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00378	0.00378	CcSEcCtD
Bromhexine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00377	0.00377	CcSEcCtD
Bromhexine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00376	0.00376	CcSEcCtD
Bromhexine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00373	0.00373	CcSEcCtD
Bromhexine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00369	0.00369	CcSEcCtD
Bromhexine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00368	0.00368	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00365	0.00365	CcSEcCtD
Bromhexine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00363	0.00363	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00362	0.00362	CcSEcCtD
Bromhexine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.0036	0.0036	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00357	0.00357	CcSEcCtD
Bromhexine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00351	0.00351	CcSEcCtD
Bromhexine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.0035	0.0035	CcSEcCtD
Bromhexine—Vomiting—Glipizide—type 2 diabetes mellitus	0.0035	0.0035	CcSEcCtD
Bromhexine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00349	0.00349	CcSEcCtD
Bromhexine—Rash—Glipizide—type 2 diabetes mellitus	0.00347	0.00347	CcSEcCtD
Bromhexine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00346	0.00346	CcSEcCtD
Bromhexine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00345	0.00345	CcSEcCtD
Bromhexine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00339	0.00339	CcSEcCtD
Bromhexine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00336	0.00336	CcSEcCtD
Bromhexine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00336	0.00336	CcSEcCtD
Bromhexine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00335	0.00335	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00329	0.00329	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00328	0.00328	CcSEcCtD
Bromhexine—Nausea—Glipizide—type 2 diabetes mellitus	0.00327	0.00327	CcSEcCtD
Bromhexine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00326	0.00326	CcSEcCtD
Bromhexine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00325	0.00325	CcSEcCtD
Bromhexine—Rash—Glimepiride—type 2 diabetes mellitus	0.00324	0.00324	CcSEcCtD
Bromhexine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00323	0.00323	CcSEcCtD
Bromhexine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00323	0.00323	CcSEcCtD
Bromhexine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00322	0.00322	CcSEcCtD
Bromhexine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00317	0.00317	CcSEcCtD
Bromhexine—Angioedema—Losartan—type 2 diabetes mellitus	0.00316	0.00316	CcSEcCtD
Bromhexine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00312	0.00312	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00311	0.00311	CcSEcCtD
Bromhexine—Skin disorder—Metformin—type 2 diabetes mellitus	0.00309	0.00309	CcSEcCtD
Bromhexine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00308	0.00308	CcSEcCtD
Bromhexine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00305	0.00305	CcSEcCtD
Bromhexine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00304	0.00304	CcSEcCtD
Bromhexine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00302	0.00302	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00301	0.00301	CcSEcCtD
Bromhexine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.003	0.003	CcSEcCtD
Bromhexine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00299	0.00299	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00298	0.00298	CcSEcCtD
Bromhexine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00294	0.00294	CcSEcCtD
Bromhexine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00292	0.00292	CcSEcCtD
Bromhexine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00292	0.00292	CcSEcCtD
Bromhexine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00291	0.00291	CcSEcCtD
Bromhexine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.0029	0.0029	CcSEcCtD
Bromhexine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00282	0.00282	CcSEcCtD
Bromhexine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0028	0.0028	CcSEcCtD
Bromhexine—Urticaria—Valsartan—type 2 diabetes mellitus	0.00277	0.00277	CcSEcCtD
Bromhexine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00275	0.00275	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00274	0.00274	CcSEcCtD
Bromhexine—Urticaria—Orlistat—type 2 diabetes mellitus	0.00274	0.00274	CcSEcCtD
Bromhexine—Angioedema—Ramipril—type 2 diabetes mellitus	0.00271	0.00271	CcSEcCtD
Bromhexine—Vomiting—Glyburide—type 2 diabetes mellitus	0.00269	0.00269	CcSEcCtD
Bromhexine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00269	0.00269	CcSEcCtD
Bromhexine—Rash—Glyburide—type 2 diabetes mellitus	0.00267	0.00267	CcSEcCtD
Bromhexine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00267	0.00267	CcSEcCtD
Bromhexine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.0026	0.0026	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00259	0.00259	CcSEcCtD
Bromhexine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00257	0.00257	CcSEcCtD
Bromhexine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00254	0.00254	CcSEcCtD
Bromhexine—Urticaria—Metformin—type 2 diabetes mellitus	0.00253	0.00253	CcSEcCtD
Bromhexine—Nausea—Glyburide—type 2 diabetes mellitus	0.00251	0.00251	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00251	0.00251	CcSEcCtD
Bromhexine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00247	0.00247	CcSEcCtD
Bromhexine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00244	0.00244	CcSEcCtD
Bromhexine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00242	0.00242	CcSEcCtD
Bromhexine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00242	0.00242	CcSEcCtD
Bromhexine—Rash—Gliclazide—type 2 diabetes mellitus	0.0024	0.0024	CcSEcCtD
Bromhexine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00239	0.00239	CcSEcCtD
Bromhexine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00239	0.00239	CcSEcCtD
Bromhexine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00238	0.00238	CcSEcCtD
Bromhexine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00236	0.00236	CcSEcCtD
Bromhexine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00235	0.00235	CcSEcCtD
Bromhexine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00226	0.00226	CcSEcCtD
Bromhexine—Pruritus—Metformin—type 2 diabetes mellitus	0.00225	0.00225	CcSEcCtD
Bromhexine—Urticaria—Losartan—type 2 diabetes mellitus	0.00224	0.00224	CcSEcCtD
Bromhexine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00222	0.00222	CcSEcCtD
Bromhexine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00221	0.00221	CcSEcCtD
Bromhexine—Rash—Valsartan—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Bromhexine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.0022	0.0022	CcSEcCtD
Bromhexine—Vomiting—Orlistat—type 2 diabetes mellitus	0.00219	0.00219	CcSEcCtD
Bromhexine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00218	0.00218	CcSEcCtD
Bromhexine—Rash—Orlistat—type 2 diabetes mellitus	0.00218	0.00218	CcSEcCtD
Bromhexine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00217	0.00217	CcSEcCtD
Bromhexine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00212	0.00212	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00209	0.00209	CcSEcCtD
Bromhexine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00208	0.00208	CcSEcCtD
Bromhexine—Nausea—Valsartan—type 2 diabetes mellitus	0.00207	0.00207	CcSEcCtD
Bromhexine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Bromhexine—Nausea—Orlistat—type 2 diabetes mellitus	0.00205	0.00205	CcSEcCtD
Bromhexine—Vomiting—Metformin—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Bromhexine—Rash—Metformin—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Bromhexine—Dermatitis—Metformin—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Bromhexine—Pruritus—Losartan—type 2 diabetes mellitus	0.002	0.002	CcSEcCtD
Bromhexine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Bromhexine—Urticaria—Ramipril—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Bromhexine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Bromhexine—Rash—Irbesartan—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Bromhexine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Bromhexine—Nausea—Metformin—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Bromhexine—Vomiting—Losartan—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Bromhexine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Bromhexine—Nausea—Irbesartan—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Bromhexine—Rash—Losartan—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Bromhexine—Dermatitis—Losartan—type 2 diabetes mellitus	0.00178	0.00178	CcSEcCtD
Bromhexine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Bromhexine—Nausea—Losartan—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Bromhexine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Bromhexine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00154	0.00154	CcSEcCtD
Bromhexine—Rash—Ramipril—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Bromhexine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Bromhexine—Nausea—Ramipril—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
